ASP Isotopes (NASDAQ:ASPI) Director Todd Wider Sells 50,000 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) Director Todd Wider sold 50,000 shares of the business’s stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $6.25, for a total transaction of $312,500.00. Following the transaction, the director owned 722,247 shares in the company, valued at $4,514,043.75. This represents a 6.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

ASP Isotopes Price Performance

ASPI stock opened at $6.17 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.39 and a quick ratio of 4.37. ASP Isotopes Inc. has a 1 year low of $3.92 and a 1 year high of $14.49. The firm has a 50-day moving average of $6.24 and a 200 day moving average of $5.90. The company has a market cap of $776.80 million, a P/E ratio of -2.97 and a beta of 3.51.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.06. The firm had revenue of $8.36 million for the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ASPI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of ASP Isotopes by 9.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after acquiring an additional 2,709 shares during the last quarter. Rhumbline Advisers raised its position in shares of ASP Isotopes by 20.9% in the 2nd quarter. Rhumbline Advisers now owns 78,994 shares of the company’s stock worth $581,000 after purchasing an additional 13,668 shares during the last quarter. XTX Topco Ltd bought a new position in ASP Isotopes in the 2nd quarter worth about $178,000. New York State Common Retirement Fund boosted its stake in ASP Isotopes by 418.2% in the 2nd quarter. New York State Common Retirement Fund now owns 17,100 shares of the company’s stock worth $126,000 after purchasing an additional 13,800 shares in the last quarter. Finally, Invesco Ltd. grew its position in ASP Isotopes by 2,205.0% during the 2nd quarter. Invesco Ltd. now owns 471,219 shares of the company’s stock valued at $3,468,000 after purchasing an additional 450,776 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on ASPI. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.